PL2240193T3 - Kompozycja zawierająca extrakty Lindera Obtusiloba do zapobiegania i leczenia chorób układu sercowo-naczyniowego - Google Patents

Kompozycja zawierająca extrakty Lindera Obtusiloba do zapobiegania i leczenia chorób układu sercowo-naczyniowego

Info

Publication number
PL2240193T3
PL2240193T3 PL08870964T PL08870964T PL2240193T3 PL 2240193 T3 PL2240193 T3 PL 2240193T3 PL 08870964 T PL08870964 T PL 08870964T PL 08870964 T PL08870964 T PL 08870964T PL 2240193 T3 PL2240193 T3 PL 2240193T3
Authority
PL
Poland
Prior art keywords
extracts
prevention
treatment
composition
cardiovascular diseases
Prior art date
Application number
PL08870964T
Other languages
English (en)
Inventor
Min-Ho Oak
Jung-Ok Lee
Woon-Sun Choi
Jung-Duk Sohn
Jong-Hoon Kim
Jee Woong Lim
Chung Keun Rhee
Original Assignee
Yang Ji Chemical Company Ltd
Han Wha Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yang Ji Chemical Company Ltd, Han Wha Pharma Co Ltd filed Critical Yang Ji Chemical Company Ltd
Publication of PL2240193T3 publication Critical patent/PL2240193T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PL08870964T 2008-01-18 2008-12-17 Kompozycja zawierająca extrakty Lindera Obtusiloba do zapobiegania i leczenia chorób układu sercowo-naczyniowego PL2240193T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020080005672A KR100989093B1 (ko) 2008-01-18 2008-01-18 생강나무 가지의 추출물을 포함하는 심혈관계 질환의 예방 및 치료용 조성물
EP08870964A EP2240193B1 (en) 2008-01-18 2008-12-17 Composition comprising the extracts of lindera obtusiloba for prevention and treatment of cardiovascular diseases
PCT/KR2008/007484 WO2009091120A2 (en) 2008-01-18 2008-12-17 Composition comprising the extracts of lindera obtusiloba for prevention and treatment of cardiovascular diseases

Publications (1)

Publication Number Publication Date
PL2240193T3 true PL2240193T3 (pl) 2013-03-29

Family

ID=40885750

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08870964T PL2240193T3 (pl) 2008-01-18 2008-12-17 Kompozycja zawierająca extrakty Lindera Obtusiloba do zapobiegania i leczenia chorób układu sercowo-naczyniowego

Country Status (8)

Country Link
US (1) US8734866B2 (pl)
EP (1) EP2240193B1 (pl)
JP (1) JP2011509996A (pl)
KR (1) KR100989093B1 (pl)
CN (1) CN101951934A (pl)
ES (1) ES2398371T3 (pl)
PL (1) PL2240193T3 (pl)
WO (1) WO2009091120A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101124442B1 (ko) * 2009-09-14 2012-03-21 영남대학교 산학협력단 생강나무 줄기의 물 추출물을 유효성분으로 함유하는 아토피성 피부염의 예방 및 개선용 화장료 조성물
KR101039628B1 (ko) * 2009-11-20 2011-06-08 양지화학 주식회사 생강나무 추출물을 유효성분으로 함유하는 혈행개선 조성물
KR101283810B1 (ko) * 2011-04-13 2013-07-08 고려대학교 산학협력단 생강나무로부터 쿼세틴-３-０-알파-람노사이드 및 캠페롤-３-０-알파-람노사이드의 분리 방법 및 그것의 항산화 또는 간 보호 용도
KR101185106B1 (ko) * 2012-02-10 2012-09-21 한국과학기술연구원 생강나무속 식물 추출물을 포함하는 안압 하강용 조성물
KR102016078B1 (ko) 2012-11-30 2019-08-30 (주)아모레퍼시픽 심장 질환 예방 또는 치료용 조성물
KR101549746B1 (ko) * 2013-08-22 2015-09-04 충북대학교 산학협력단 생강의 용매분획을 유효성분으로 포함하는 기능성 위장장애 및 위장관 운동장애의 예방 및 치료용 약학적 조성물
CN104147542A (zh) * 2014-08-29 2014-11-19 韩世昌 一种治疗风湿性类风湿关节炎的膏药及其制备方法
KR102232330B1 (ko) * 2018-02-21 2021-03-26 경북대학교 산학협력단 생강나무 잎 추출물을 유효성분으로 포함하는 비만 또는 비만 관련 합병증의 예방, 치료, 또는 개선용 조성물
CN117942340A (zh) * 2022-10-31 2024-04-30 深圳先进技术研究院 乌药碱及其衍生物在提高nampt活性中的应用和药物组合物
CN120131687A (zh) * 2025-04-22 2025-06-13 浙江大学中原研究院 天竺葵素-3-葡萄糖苷在制备改善血管内皮功能障碍的产品中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0615473B2 (ja) 1985-04-12 1994-03-02 第一製薬株式会社 脳浮腫抑制剤
EP0395294A3 (en) * 1989-04-25 1991-05-22 Takeda Chemical Industries, Ltd. Control of protozoal disease
JPH06135830A (ja) * 1992-10-23 1994-05-17 Natl Sci Council フラボノイド誘導体を含有する抗高血圧薬組成物
US5763496A (en) 1995-11-27 1998-06-09 The Research Foundation Of State University Of New York Prevention of atherosclerosis using NADPH oxidase inhibitors
ES2214753T3 (es) 1997-11-14 2004-09-16 United Therapeutics Corporation Uso de 9-desoxi-2',9-alfa-metano-3-oxa-4,5,6-trinor-3,7-(1',3'-interfenilen)-13,14-dihidro-prostaglandina f1 para tratar la enfermedad vascular periferica.
ES2203078T3 (es) 1998-04-20 2004-04-01 Pfizer Inc. Parazolopirimidinonas inhibidoras de gmpc pde5 para el tratamiento de la disfuncion sexual.
JP4515556B2 (ja) * 1999-05-31 2010-08-04 日本製粉株式会社 脂肪蓄積抑制剤、抗肥満剤、食品添加物、食品及びペットフード
US20010034340A1 (en) 2000-03-20 2001-10-25 American Home Products Corporation Hormone replacement therapy
JO2654B1 (en) 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
PL212952B1 (pl) 2000-10-26 2012-12-31 Fournier Lab Ireland Ltd Kompozycja farmaceutyczna zawierajaca fenofibrat i koenzym Q₁₀ oraz jej zastosowanie
SI1373263T1 (en) 2001-04-05 2005-04-30 Torrent Pharmaceuticals Ltd Heterocyclic compounds for aging-related and diabetic vascular complications
BRPI0412236A (pt) 2003-07-02 2006-09-12 Hoffmann La Roche compostos, processo para a sua manufatura, composições farmacêuticas que compreendem os mesmos, método para o tratamento e/ou prevenção de enfermidades que são moduladas por agonistas ppar(delta) e/ou ppar(alfa), e utilização desses compostos
US20070160699A1 (en) * 2004-01-31 2007-07-12 Kiyoung Kim Composition comprising hovenia dulcis thunb. extract, lindera obtusiloba blume extract, or herbal mixture extract thereof
WO2005097746A2 (en) 2004-04-12 2005-10-20 Torrent Pharmaceuticals Ltd 2-propene-1-ones as hsp 70 inducers
CN1742801A (zh) * 2005-10-07 2006-03-08 张益群 一种千斤拔外用药
KR100732886B1 (ko) 2005-11-07 2007-06-27 한국화학연구원 목단피 추출물 또는 이로부터 분리된 활성성분을 포함하는 혈압강하용 조성물
KR100732888B1 (ko) 2005-12-21 2007-06-27 한국화학연구원 대황 추출물 또는 이로부터 분리된 활성성분을 포함하는혈압 강하용 조성물
KR100948332B1 (ko) 2008-01-18 2010-03-17 양지화학 주식회사 큰까치수영 추출물을 포함하는 심혈관계 질환의 예방 및치료용 조성물

Also Published As

Publication number Publication date
CN101951934A (zh) 2011-01-19
EP2240193A4 (en) 2011-04-27
WO2009091120A3 (en) 2009-10-15
EP2240193A2 (en) 2010-10-20
ES2398371T3 (es) 2013-03-15
JP2011509996A (ja) 2011-03-31
US8734866B2 (en) 2014-05-27
EP2240193B1 (en) 2012-10-24
KR20090079584A (ko) 2009-07-22
KR100989093B1 (ko) 2010-10-25
WO2009091120A2 (en) 2009-07-23
US20110045111A1 (en) 2011-02-24

Similar Documents

Publication Publication Date Title
IL272817A (en) New preparations and methods for the treatment of vaccine-related diseases
PL2118074T3 (pl) Związki chemiczne do celów profilaktyki i leczenia chorób układu sercowo-naczyniowego
EP2240193A4 (en) COMPOSITION COMPRISING LINDERA OBTUSILOBA EXTRACTS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASES
PT2546253E (pt) Di-hidropirazolonas substituídas para o tratamento de doenças cardiovasculares e hematológicas
IL184312A0 (en) Herbal compositions for the treatment of diabetes and/or conditions associated therewith
EP2007385A4 (en) CARDIOVASCULAR COMPOSITION AND ITS USE FOR THE TREATMENT OF MORBUS ALZHEIMER
EP2405755A4 (en) METHOD AND COMPOSITIONS FOR TREATING METABOLISM AND CARDIOVASCULAR DISEASES
PT2322221E (pt) Composição farmacêutica para tratamento e prevenção de cancro
IL207713A0 (en) Formulation and method for the prevention and treatment of bone metastases or other bone diseases
PL2340042T3 (pl) Sposoby i kompozycje do leczenia raka
IL210810A0 (en) Compositions for the treatment of pain and/or inflamtion
ZA201105287B (en) Prevention and treatment of rotavirus diarrhoea
IL196843A0 (en) Compositions and methods for the treatment of radiation proctosigmoitis
IL193936A0 (en) Compositions and methods for the treatment of immunoinflammatory disorders
EP2331123A4 (en) COMPOSITIONS AND METHODS FOR TREATING HEPATITIS C
AU2007243282A8 (en) Compositions and methods for the treatment of cardiovascular disease
EP2282648A4 (en) PREBIOTIC COMPOSITIONS AND MANUFACTURING AND USE METHOD THEREFOR
IL208455A0 (en) Capsule for the prevention of cardiovascular diseases
ZA200908100B (en) Treatment and prevention of influenza
GB0610350D0 (en) prevention and/or treatment of neuodegenerative disorders
PL2305300T3 (pl) Kompozycja farmaceutyczna do leczenia i zapobiegania nowotworowi
EP2405747A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF CARDIOVASCULAR DISEASES
IL200570A0 (en) Combination therapy, composition and methods for the treatment of cardiovascular disorders
EP2240190A4 (en) NUTRITIONAL COMPOSITION AND METHOD OF USE
EP2480099A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING METABOLIC DISEASES